(1) Criteria for the use of vitamin B12 (a) approved value in the treatment of pernicious anaemia only (other conditions are very rare in British general practice)
Metabolic Pharmaceuticals terminated drug development in March 2007
This comprehensive review examines 6 research-backed benefits of 5-amino-1MQ, ranked by evidence strength
The net result of AOD9604 action is preferential reduction of adipose tissue mass, particularly visceral and subcutaneous fat depots, without the hyperglycemic, insulin-desensitizing, or growth-promoting effects of full-length growth hormone
Rotate injection sites with each dose to prevent lipodystrophy (lumps or pits at the injection site)
These limitations dont invalidate the positive safety findings but do suggest that comprehensive medical supervision remains appropriate for anyone using AOD-9604, particularly for off-label applications or extended treatment periods